Literature DB >> 19653121

Identification and characterization of human LYPD6, a new member of the Ly-6 superfamily.

Yifeng Zhang1, Qingyu Lang, Jie Li, Fang Xie, Bo Wan, Long Yu.   

Abstract

The Ly-6 protein superfamily is usually identified as a group of proteins with a LU protein domain. LU domain is about 80 amino acids long and characterized by a conserved pattern of 10 cysteine residues. Here we report the cloning and characterization of a novel human LU domain containing gene, LYPD6, isolated from human testis cDNA library, and mapped to 2q23.1-23.2 by searching the UCSC genomic database. The LYPD6 cDNA sequence of 3,501 base pairs contains an open reading frame encoding 171 amino acids. Subcellular localization of LYPD6 demonstrated that the protein was localized in the cytoplasm when overexpressed in COS-7 cells. RT-PCR analysis showed that LYPD6 was widely expressed in human tissues and the expression levels in brain and heart were relatively high. Furthermore, the subsequent analysis based on reporter gene assays suggested that overexpression of LYPD6 in HEK 293T cells was able to suppress the transcriptional activities of AP1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653121     DOI: 10.1007/s11033-009-9663-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  31 in total

Review 1.  Snake venom alpha-neurotoxins and other 'three-finger' proteins.

Authors:  V Tsetlin
Journal:  Eur J Biochem       Date:  1999-09

2.  lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS.

Authors:  J M Miwa; I Ibanez-Tallon; G W Crabtree; R Sánchez; A Sali; L W Role; N Heintz
Journal:  Neuron       Date:  1999-05       Impact factor: 17.173

3.  Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse.

Authors:  Tao Xie; Lee Rowen; Begoña Aguado; Mary Ellen Ahearn; Anup Madan; Shizhen Qin; R Duncan Campbell; Leroy Hood
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

4.  Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1.

Authors:  Ryoichi X Ioka; Man-Jong Kang; Shin Kamiyama; Dong-Ho Kim; Kenta Magoori; Akihisa Kamataki; Yuichiro Ito; Yumiko A Takei; Masako Sasaki; Takashi Suzuki; Hironobu Sasano; Sadao Takahashi; Juro Sakai; Takahiro Fujino; Tokuo T Yamamoto
Journal:  J Biol Chem       Date:  2002-12-20       Impact factor: 5.157

5.  Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.

Authors:  R E Reiter; Z Gu; T Watabe; G Thomas; K Szigeti; E Davis; M Wahl; S Nisitani; J Yamashiro; M M Le Beau; M Loda; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

6.  The characterisation of novel secreted Ly-6 proteins from rat urine by the combined use of two-dimensional gel electrophoresis, microbore high performance liquid chromatography and expressed sequence tag data.

Authors:  Christopher Southan; Paul Cutler; Helen Birrell; John Connell; Kenneth G M Fantom; Matthew Sims; Narjis Shaikh; Klaus Schneider
Journal:  Proteomics       Date:  2002-02       Impact factor: 3.984

7.  Characterization of two novel Ly-6 genes. Protein sequence and potential structural similarity to alpha-bungarotoxin and other neurotoxins.

Authors:  T J Fleming; C O'hUigin; T R Malek
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

Review 8.  Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4.

Authors:  Matthew R Young; Hsin-Sheng Yang; Nancy H Colburn
Journal:  Trends Mol Med       Date:  2003-01       Impact factor: 11.951

Review 9.  Tissue expression, structure and function of the murine Ly-6 family of molecules.

Authors:  T P Gumley; I F McKenzie; M S Sandrin
Journal:  Immunol Cell Biol       Date:  1995-08       Impact factor: 5.126

10.  A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras.

Authors:  Z Q Wang; A E Grigoriadis; U Möhle-Steinlein; E F Wagner
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

View more
  14 in total

1.  Isoform-specific mechanisms of α3β4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1.

Authors:  Andrew A George; Abigail Bloy; Julie M Miwa; Jon M Lindstrom; Ronald J Lukas; Paul Whiteaker
Journal:  FASEB J       Date:  2017-01-18       Impact factor: 5.191

2.  Lypd8 promotes the segregation of flagellated microbiota and colonic epithelia.

Authors:  Ryu Okumura; Takashi Kurakawa; Takashi Nakano; Hisako Kayama; Makoto Kinoshita; Daisuke Motooka; Kazuyoshi Gotoh; Taishi Kimura; Naganori Kamiyama; Takashi Kusu; Yoshiyasu Ueda; Hong Wu; Hideki Iijima; Soumik Barman; Hideki Osawa; Hiroshi Matsuno; Junichi Nishimura; Yusuke Ohba; Shota Nakamura; Tetsuya Iida; Masahiro Yamamoto; Eiji Umemoto; Koichi Sano; Kiyoshi Takeda
Journal:  Nature       Date:  2016-03-30       Impact factor: 49.962

3.  The prototoxin LYPD6B modulates heteromeric α3β4-containing nicotinic acetylcholine receptors, but not α7 homomers.

Authors:  Vanessa Ochoa; Andrew A George; Rae Nishi; Paul Whiteaker
Journal:  FASEB J       Date:  2015-11-19       Impact factor: 5.191

4.  Mid-gestational gene expression profile in placenta and link to pregnancy complications.

Authors:  Liis Uusküla; Jaana Männik; Kristiina Rull; Ave Minajeva; Sulev Kõks; Pille Vaas; Pille Teesalu; Jüri Reimand; Maris Laan
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 5.  Organization, evolution and functions of the human and mouse Ly6/uPAR family genes.

Authors:  Chelsea L Loughner; Elspeth A Bruford; Monica S McAndrews; Emili E Delp; Sudha Swamynathan; Shivalingappa K Swamynathan
Journal:  Hum Genomics       Date:  2016-04-21       Impact factor: 4.639

6.  Human Secreted Ly-6/uPAR Related Protein-1 (SLURP-1) Is a Selective Allosteric Antagonist of α7 Nicotinic Acetylcholine Receptor.

Authors:  Ekaterina N Lyukmanova; Mikhail A Shulepko; Denis Kudryavtsev; Maxim L Bychkov; Dmitrii S Kulbatskii; Igor E Kasheverov; Maria V Astapova; Alexey V Feofanov; Morten S Thomsen; Jens D Mikkelsen; Zakhar O Shenkarev; Victor I Tsetlin; Dmitry A Dolgikh; Mikhail P Kirpichnikov
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

7.  Identification of novel markers of mouse fetal ovary development.

Authors:  Huijun Chen; James S Palmer; Rathi D Thiagarajan; Marcel E Dinger; Emmanuelle Lesieur; Hansheng Chiu; Alexandra Schulz; Cassy Spiller; Sean M Grimmond; Melissa H Little; Peter Koopman; Dagmar Wilhelm
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

8.  High risk population isolate reveals low frequency variants predisposing to intracranial aneurysms.

Authors:  Mitja I Kurki; Emília Ilona Gaál; Johannes Kettunen; Tuuli Lappalainen; Androniki Menelaou; Verneri Anttila; Femke N G van 't Hof; Mikael von Und Zu Fraunberg; Seppo Helisalmi; Mikko Hiltunen; Hanna Lehto; Aki Laakso; Riku Kivisaari; Timo Koivisto; Antti Ronkainen; Jaakko Rinne; Lambertus A L Kiemeney; Sita H Vermeulen; Mari A Kaunisto; Johan G Eriksson; Arpo Aromaa; Markus Perola; Terho Lehtimäki; Olli T Raitakari; Veikko Salomaa; Murat Gunel; Emmanouil T Dermitzakis; Ynte M Ruigrok; Gabriel J E Rinkel; Mika Niemelä; Juha Hernesniemi; Samuli Ripatti; Paul I W de Bakker; Aarno Palotie; Juha E Jääskeläinen
Journal:  PLoS Genet       Date:  2014-01-30       Impact factor: 5.917

Review 9.  Characterization and function of human Ly-6/uPAR molecules.

Authors:  Hyun Kyung Kong; Jong Hoon Park
Journal:  BMB Rep       Date:  2012-11       Impact factor: 4.778

10.  Functional interaction between Lypd6 and nicotinic acetylcholine receptors.

Authors:  Maria Arvaniti; Majbrit M Jensen; Neeraj Soni; Hong Wang; Anders B Klein; Nathalie Thiriet; Lars H Pinborg; Pretal P Muldoon; Jacob Wienecke; M Imad Damaj; Kristi A Kohlmeier; Marjorie C Gondré-Lewis; Jens D Mikkelsen; Morten S Thomsen
Journal:  J Neurochem       Date:  2016-08-15       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.